key: cord-020316-xr9h4c1q
authors: nan
title: Million women study most wanted in 2003
date: 2004-04-10
journal: Lancet
DOI: 10.1016/s0140-6736(04)15948-5
sha: 
doc_id: 20316
cord_uid: xr9h4c1q

nan

The year 2003

hormone-replacement therapy in the Million Women Study

Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebo-controlled trial

Poulter NR for the ASCOT investigators. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial

Coronavirus as a possible cause of severe acute respiratory syndrome

Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial

Advances in cystic fibrosis

Cystic fibrosis

Elusive schizophrenia genes

Genes for schizophrenia? Recent findings and their pathophysiological implications

Detecting ovarian cancer

Use of proteomic patterns in serum to identify ovarian cancer

Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial

COOPERATion

Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial